Efficacy and safety of semaglutide in patients with heart failure with preserved ejection fraction and obesity.

Clin Cardiol · 2024 · PMC11103635 · PMID 38767042

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

Although the differences did not reach statistical significance, the semaglutide group showed a trend towards reduced systolic blood pressure (−1.8 mmHg) and decreased waist circumference (−6.7 cm).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.